Clinical Trials
2 trialsNCT02175017 2024-12-09
ONO-4538 Study in Patients With Advanced Non-Small Cell Lung Cancer
Ono Pharmaceutical Co., Ltd.
Phase 2 Completed
NCT01101334 2020-06-16
Study of Erlotinib With or Without Investigational Drug (CS-7017) in Subjects With Advanced Non-small Cell Lung Cancer
Daiichi Sankyo
Phase 2 Completed